Key result
Factor Xa inhibitors provide effective anticoagulation in the next generation treatment of atrial fibrillation.
Key points are not available for this paper at this time.
May inform AF anticoagulation choices; leaves open need for confirmatory randomized trials before practice change.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Kaba et al. (2013) studied this question. Factor Xa inhibitors provide effective anticoagulation in the next generation treatment of atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: